Cargando…
Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy
OBJECTIVES: Vγ9Vδ2 T-cells are a subset of T-cells with a crucial role in immunosurveillance which can be activated and expanded by multiple means to stimulate effector responses. Little is known about the expression of checkpoint molecules on this cell population and whether the ligation of these m...
Autores principales: | Ridgley, Laura A., Caron, Jonathan, Dalgleish, Angus, Bodman-Smith, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880221/ https://www.ncbi.nlm.nih.gov/pubmed/36713444 http://dx.doi.org/10.3389/fimmu.2022.1065495 |
Ejemplares similares
-
Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2(+) T cells compared with the aminobisphosphonate drug zoledronic acid
por: Fenn, J, et al.
Publicado: (2022) -
How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era
por: Caron, Jonathan, et al.
Publicado: (2021) -
Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
por: Hoeres, Timm, et al.
Publicado: (2018) -
Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?
por: Giannotta, Claudia, et al.
Publicado: (2023) -
Beneficial Effect of Antibiotics and Microbial Metabolites on Expanded Vδ2Vγ9 T Cells in Hepatocellular Carcinoma Immunotherapy
por: Han, Jiajia, et al.
Publicado: (2020)